Samhati Mondal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Samhati Mondal has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
Roumen Vesselinov
Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, USA
3 shared publicationsStephanie O. Ibekwe
Department of Anesthesiology, Baylor College of Medicine, Houston, USA
3 shared publicationsAnubhav Kapoor
Mercy General Hospital
2 shared publicationsBrian Bush
Johns Hopkins Medicine
2 shared publicationsBrian Cho
Johns Hopkins Medicine
2 shared publicationsBrittney Williams
From the Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland
2 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 15 (5) , 68
Intraoperative methadone for cardiac surgery: is it time to embrace it?
Intraoperative methadone for cardiac surgery: is it time to embrace it?
- 1 September 2026
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 15 (5) , 68
Open AccessIntraoperative methadone for cardiac surgery: is it time to embrace it?
Intraoperative methadone for cardiac surgery: is it time to embrace it?
- Open Access
- 1 July 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Contemporary approaches to extracorporeal membrane oxygenation usage in extended peripartum period over a decade – a systematic review
Extracorporeal membrane oxygenation (ECMO) has become a valuable tool in critical care medicine when conventional treatment to severe cardiopulmonary failu
- 1 July 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessContemporary approaches to extracorporeal membrane oxygenation usage in extended peripartum period over a decade – a systematic review
Extracorporeal membrane oxygenation (ECMO) has become a valuable tool in critical care medicine when conventional treatment to severe cardiopulmonary failu
- 15 June 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 143 (4) , 679-682
Frailty in Cardiac Surgery—Is It the Missing Link in the Era of Precision Medicine
- 15 June 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 143 (4) , 679-682
Frailty in Cardiac Surgery—Is It the Missing Link in the Era of Precision Medicine
- 14 April 2026
- Published by Springer Nature in Current Anesthesiology Reports
- Vol. 16 (1)
Viscoelastic Coagulation Testing in the Perioperative Period – Pros and Cons
- 14 April 2026
- Published by Springer Nature in Current Anesthesiology Reports
- Vol. 16 (1)
Viscoelastic Coagulation Testing in the Perioperative Period – Pros and Cons
- 1 October 2025
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 72 (10) , 1593-1594
In reply: Desmopressin in kidney transplantation: much ado about reduced urine output?
- 1 October 2025
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 72 (10) , 1593-1594
In reply: Desmopressin in kidney transplantation: much ado about reduced urine output?
- 21 March 2025
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 72 (4) , 540-549
Impact of intraoperative desmopressin on postoperative urine output in adult cadaveric kidney transplantation: a single-centre retrospective cohort study
Purpose Desmopressin, a synthetic analogue of vasopressin, is used to prevent uremic bleeding in patients undergoing kidney transplantation but can cause oliguria. Graft function assessment is crucial after kidney transplantation. Urine output (UOP) is the simplest, most feasible, and most cost-effective perioperative monitoring tool to assess graft function in kidney transplantation. No study, to our knowledge, has yet assessed this association in the setting of cadaveric adult kidney transplantation. Methods We conducted a retrospective single-centre cohort study to evaluate the impact of desmopressin on UOP in the immediate postoperative period after kidney transplantation at a tertiary care academic hospital in Baltimore, MD, USA. We included a total of 938 adults who received a cadaveric kidney transplant from January 2016 to December 2022 in the study after reviewing selection criteria. As the primary outcome, we compared immediate postoperative UOP (mL·kg−1) between recipients of desmopressin and nonrecipients of desmopressin. The secondary outcomes of the study were UOP at 12 and 24 hr postoperatively, estimated blood loss (EBL), and postoperative hemoglobin. Results Three hundred and fifty-nine (38%) patients received desmopressin intraoperatively. Using multivariable linear regression, desmopressin use was associated with 0.6 mL·kg−1 lower UOP, representing an average 19% reduction in UOP from a mean UOP of 3.1 mL·kg−1 in the operating room after adjusting for confounders. A similar reduction in 12- and 24-hr postoperative UOP was also noted (3 mL·kg−1 and 6 mL·kg−1, respectively), while desmopressin was associated with a slightly higher EBL. We also observed a dilutional reduction in postoperative hemoglobin. Conclusions Intraoperative desmopressin in adult cadaveric kidney transplant recipients was associated with reduced urine output in the postoperative period without any significant hemostatic benefit.
- 21 March 2025
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 72 (4) , 540-549
Impact of intraoperative desmopressin on postoperative urine output in adult cadaveric kidney transplantation: a single-centre retrospective cohort study
Purpose Desmopressin, a synthetic analogue of vasopressin, is used to prevent uremic bleeding in patients undergoing kidney transplantation but can cause oliguria. Graft function assessment is crucial after kidney transplantation. Urine output (UOP) is the simplest, most feasible, and most cost-effective perioperative monitoring tool to assess graft function in kidney transplantation. No study, to our knowledge, has yet assessed this association in the setting of cadaveric adult kidney transplantation. Methods We conducted a retrospective single-centre cohort study to evaluate the impact of desmopressin on UOP in the immediate postoperative period after kidney transplantation at a tertiary care academic hospital in Baltimore, MD, USA. We included a total of 938 adults who received a cadaveric kidney transplant from January 2016 to December 2022 in the study after reviewing selection criteria. As the primary outcome, we compared immediate postoperative UOP (mL·kg−1) between recipients of desmopressin and nonrecipients of desmopressin. The secondary outcomes of the study were UOP at 12 and 24 hr postoperatively, estimated blood loss (EBL), and postoperative hemoglobin. Results Three hundred and fifty-nine (38%) patients received desmopressin intraoperatively. Using multivariable linear regression, desmopressin use was associated with 0.6 mL·kg−1 lower UOP, representing an average 19% reduction in UOP from a mean UOP of 3.1 mL·kg−1 in the operating room after adjusting for confounders. A similar reduction in 12- and 24-hr postoperative UOP was also noted (3 mL·kg−1 and 6 mL·kg−1, respectively), while desmopressin was associated with a slightly higher EBL. We also observed a dilutional reduction in postoperative hemoglobin. Conclusions Intraoperative desmopressin in adult cadaveric kidney transplant recipients was associated with reduced urine output in the postoperative period without any significant hemostatic benefit.
- 7 November 2024
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 141 (6) , 1216-1217
Transfusions in Lung Transplantation: Comment
ANESTHESIOLOGY is the highest-impact, peer-reviewed medical journal that publishes trusted evidence that transforms the practice of perioperative,
- 7 November 2024
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 141 (6) , 1216-1217
Transfusions in Lung Transplantation: Comment
ANESTHESIOLOGY is the highest-impact, peer-reviewed medical journal that publishes trusted evidence that transforms the practice of perioperative,
- 21 February 2024
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (5) , 1272-1274
Methadone Should Not Be Used in Cardiac Surgery as Part of Enhanced Recovery After Cardiac Surgery Protocol
- 21 February 2024
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (5) , 1272-1274
Methadone Should Not Be Used in Cardiac Surgery as Part of Enhanced Recovery After Cardiac Surgery Protocol
- 24 January 2024
- Published by Wiley in Transfusion
- Vol. 64 (3) , 467-474
Protamine dosing and its impact in cardiac surgery transfusion practice—A retrospective bi‐institutional analysis
Background: Bleeding after cardiac surgery is common and continues to require 10–20% of the national blood supply. Transfusion of allogeneic blood is associated with increased morbidity and mortality. Excessive protamine in the absence of circulating heparin after weaning off CPB can cause anticoagulation and precipitate bleeding. Hence, adequate dose calculation of protamine is crucial yet under evaluated.Study Design: Retrospective cohort study.Methods: We conducted a retrospective bi‐institutional analysis of cardiac surgical patients who underwent cardiopulmonary bypass (CPB)‐assisted cardiac surgery to assess the impact of protamine dosing in transfusion practice. Total 762 patients were identified from two institutions using electronic medical records and the Society of Thoracic Surgery (STS) database who underwent cardiac surgery using CPB. Patients were similar in demographics and other baseline characteristics. We divided patients into two groups based on mg of protamine administered to neutralize each 100 U of unfractionated heparin (UFH)—low‐ratio group (Protamine: UFH ≤ 0.8) and high‐ratio group (Protamine: UFH > 0.8).Results: We observed a higher rate of blood transfusion required in high‐ratio group (ratio >0.8) compared with low‐ratio group (ratio ≤0.8) (p < .001). The increased requirement was consistently demonstrated for intraoperative transfusions of red blood cells, plasma, platelets, and cryoprecipitate.Conclusion: High protamine to heparin ratio may cause increased bleeding and transfusion in cardiac surgical patients. Protamine to heparin ratio of 0.8 or lower is sufficient to neutralize circulating heparin after weaning off cardiopulmonary bypass.
- 24 January 2024
- Published by Wiley in Transfusion
- Vol. 64 (3) , 467-474
Protamine dosing and its impact in cardiac surgery transfusion practice—A retrospective bi‐institutional analysis
Background: Bleeding after cardiac surgery is common and continues to require 10–20% of the national blood supply. Transfusion of allogeneic blood is associated with increased morbidity and mortality. Excessive protamine in the absence of circulating heparin after weaning off CPB can cause anticoagulation and precipitate bleeding. Hence, adequate dose calculation of protamine is crucial yet under evaluated.Study Design: Retrospective cohort study.Methods: We conducted a retrospective bi‐institutional analysis of cardiac surgical patients who underwent cardiopulmonary bypass (CPB)‐assisted cardiac surgery to assess the impact of protamine dosing in transfusion practice. Total 762 patients were identified from two institutions using electronic medical records and the Society of Thoracic Surgery (STS) database who underwent cardiac surgery using CPB. Patients were similar in demographics and other baseline characteristics. We divided patients into two groups based on mg of protamine administered to neutralize each 100 U of unfractionated heparin (UFH)—low‐ratio group (Protamine: UFH ≤ 0.8) and high‐ratio group (Protamine: UFH > 0.8).Results: We observed a higher rate of blood transfusion required in high‐ratio group (ratio >0.8) compared with low‐ratio group (ratio ≤0.8) (p < .001). The increased requirement was consistently demonstrated for intraoperative transfusions of red blood cells, plasma, platelets, and cryoprecipitate.Conclusion: High protamine to heparin ratio may cause increased bleeding and transfusion in cardiac surgical patients. Protamine to heparin ratio of 0.8 or lower is sufficient to neutralize circulating heparin after weaning off cardiopulmonary bypass.
- 11 November 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 37 (12) , 2450-2460
Role of Cardiac Anesthesiologists in Intraoperative Enhanced Recovery After Cardiac Surgery (ERACS) Protocol: A Retrospective Single-Center Study Analyzing Preliminary Results of a Yearlong ERACS Protocol Implementation
- 11 November 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 37 (12) , 2450-2460
Role of Cardiac Anesthesiologists in Intraoperative Enhanced Recovery After Cardiac Surgery (ERACS) Protocol: A Retrospective Single-Center Study Analyzing Preliminary Results of a Yearlong ERACS Protocol Implementation